Volume | 275 |
|
|||||
News | - | ||||||
Day High | 0.0331 | Low High |
|||||
Day Low | 0.0331 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Avenir Wellness Solutions Inc (QB) | AVRW | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0331 | 0.0331 | 0.0331 | 0.0331 | 0.0331 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2 | 275 | $ 0.0331 | $ 9 | - | 0.0226 - 0.25 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
09:30:03 | 83 | $ 0.0331 | USD |
Avenir Wellness Solutions Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 2.56M | 77.47M | 40.72M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Avenir Wellness Solutions (QB) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AVRW Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.04 | 0.045 | 0.0331 | 0.0382519 | 9,362 | -0.0069 | -17.25% |
1 Month | 0.035 | 0.0555 | 0.032 | 0.0405816 | 20,199 | -0.0019 | -5.43% |
3 Months | 0.045 | 0.0555 | 0.0226 | 0.0381319 | 27,414 | -0.0119 | -26.44% |
6 Months | 0.0589 | 0.095 | 0.0226 | 0.0527312 | 46,904 | -0.0258 | -43.80% |
1 Year | 0.11 | 0.25 | 0.0226 | 0.057177 | 40,524 | -0.0769 | -69.91% |
3 Years | 0.11 | 0.25 | 0.0226 | 0.057177 | 40,524 | -0.0769 | -69.91% |
5 Years | 0.11 | 0.25 | 0.0226 | 0.057177 | 40,524 | -0.0769 | -69.91% |
Avenir Wellness Solutions (QB) Description
CURE Pharmaceutical is a broad platform technology company that develops proprietary drug, nutraceutical and topical delivery systems and currently holds fifteen patents. The technology offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and patient/consumer experience for a wide range of active ingredients. The Company will continue down the path creating new innovative technology that will be part of its incubator strategy. The Sera Labs, Inc. (Sera Labs), a wholly owned subsidiary of CURE, is a trusted leader in the wellness, and beauty sectors utilizing cutting edge technology and high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips. The Company sells its products at affordable prices, making them easily accessible on a global scale and is strategically positioned to grow their beauty and wellness products into household brands. Sera Labs products are sold Direct to Consumer with a subscribe and save option, as well as in major national drug, grocery chains, and mass retailers. For more information visit: Seratopicalrevolution.com, Seratopical.com, Seralabshealth.com and follow Sera Labs on Instagram at @seratopical, as well as Twitter and Facebook. |